Effects of bone morphogenetic protein 2 on human umbilical vein endothelial cells

Microvascular Research

Volumn 84, Issue 1, 2012, Pages 81-85

  Finkenzeller, G ^a   Hager, S ^a   Stark, G B ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALK2 PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; CELL RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL COUNT; CELL FUNCTION; CELL INVASION; CELL PROLIFERATION; CELL SPREADING; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL;

APOPTOSIS; BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RECOMBINANT PROTEINS;

EID: 84861528847     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2012.03.010     Document Type: Article

References (28)

1. Carano R.A., Filvaroff E.H. Angiogenesis and bone repair. Drug Discov. Today 2003, 8:980-989.
2. Cattaneo M.G., Chini B., Vicentini L.M. Oxytocin stimulates migration and invasion in human endothelial cells. Br. J. Pharmacol. 2008, 153:728-736.
3. Cunningham N.S., Paralkar V., Reddi A.H. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:11740-11744.
4. Date T., Doiguchi Y., Nobuta M., Shindo H. Bone morphogenetic protein-2 induces differentiation of multipotent C3H10T1/2 cells into osteoblasts, chondrocytes, and adipocytes in vivo and in vitro. J. Orthop. Sci. 2004, 9:503-508.
5. Eccles S.A. Parallels in invasion and angiogenesis provide pivotal points for therapeutic intervention. Int. J. Dev. Biol. 2004, 48:583-598.
6. Grgurevic L., Macek B., Mercep M., Jelic M., Smoljanovic T., Erjavec I., Dumic-Cule I., Prgomet S., Durdevic D., Vnuk D., et al. Bone morphogenetic protein (BMP)1-3 enhances bone repair. Biochem. Biophys. Res. Commun. 2011, 408:25-31.
7. Hou C.H., Hsiao Y.C., Fong Y.C., Tang C.H. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13. Bone 2009, 44:233-242.
8. Kang M.H., Oh S.C., Lee H.J., Kang H.N., Kim J.L., Kim J.S., Yoo Y.A. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-kappaB pathway, and MMP-9 expression. Exp. Cell Res. 2011, 317:1746-1762.
9. Karsan A., Yee E., Poirier G.G., Zhou P., Craig R., Harlan J.M. Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms. Am. J. Pathol. 1997, 151:1775-1784.
10. Langenfeld E.M., Langenfeld J. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol. Cancer Res. 2004, 2:141-149.
11. Lechleider R.J., Ryan J.L., Garrett L., Eng C., Deng C., Wynshaw-Boris A., Roberts A.B. Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion. Dev. Biol. 2001, 240:157-167.
12. Liu F., Ventura F., Doody J., Massague J. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol. Cell. Biol. 1995, 15:3479-3486.
13. Macias-Silva M., Hoodless P.A., Tang S.J., Buchwald M., Wrana J.L. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J. Biol. Chem. 1998, 273:25628-25636.
14. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 1998, 67:753-791.
15. Medhurst A.D., Harrison D.C., Read S.J., Campbell C.A., Robbins M.J., Pangalos M.N. The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J. Neurosci. Methods 2000, 98:9-20.
16. Miyazono K., Kusanagi K., Inoue H. Divergence and convergence of TGF-beta/BMP signaling. J. Cell. Physiol. 2001, 187:265-276.
17. Miyazono K., Maeda S., Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 2005, 16:251-263.
18. Nickel J., Sebald W., Groppe J.C., Mueller T.D. Intricacies of BMP receptor assembly. Cytokine Growth Factor Rev. 2009, 20:367-377.
19. Song I., Kim B.S., Kim C.S., Im G.I. Effects of BMP-2 and vitamin D3 on the osteogenic differentiation of adipose stem cells. Biochem. Biophys. Res. Commun. 2011, 408:126-131.
20. Suzuki Y., Montagne K., Nishihara A., Watabe T., Miyazono K. BMPs promote proliferation and migration of endothelial cells via stimulation of VEGF-A/VEGFR2 and angiopoietin-1/Tie2 signalling. J. Biochem. 2008, 143:199-206.
21. Teichert-Kuliszewska K., Kutryk M.J., Kuliszewski M.A., Karoubi G., Courtman D.W., Zucco L., Granton J., Stewart D.J. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ. Res. 2006, 98:209-217.
22. ten Dijke P., Ichijo H., Franzen P., Schulz P., Saras J., Toyoshima H., Heldin C.H., Miyazono K. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 1993, 8:2879-2887.
23. ten Dijke P., Yamashita H., Sampath T.K., Reddi A.H., Estevez M., Riddle D.L., Ichijo H., Heldin C.H., Miyazono K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 1994, 269:16985-16988.
24. Willette R.N., Gu J.L., Lysko P.G., Anderson K.M., Minehart H., Yue T. BMP-2 gene expression and effects on human vascular smooth muscle cells. J. Vasc. Res. 1999, 36:120-125.
25. Winnier G., Blessing M., Labosky P.A., Hogan B.L. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 1995, 9:2105-2116.
26. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., Hewick R.M., Wang E.A. Novel regulators of bone formation: molecular clones and activities. Science 1988, 242:1528-1534.
27. Xiao Y.T., Xiang L.X., Shao J.Z. Bone morphogenetic protein. Biochem. Biophys. Res. Commun. 2007, 362:550-553.
28. Yang X., Castilla L.H., Xu X., Li C., Gotay J., Weinstein M., Liu P.P., Deng C.X. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development 1999, 126:1571-1580.